Medical Innovation Is Not A Blue or Red State Issue

The Next Instagram May Change the Way You Take Pictures

But The Next Big Medical Innovation Could Save Your Life

Charles Laverty on the critical impact of medical innovatio
Charles Laverty on the critical impact of medical innovation in US competitiveness and public health.

Last week at the European Bifurcation Club meeting in Porto Portugal, ABS co-founder and chief medical officer Dr. Mehran Khorsand presented the ABS bifurcation stenting platform. We met many other dedicated doctor and professionals who are devoting their energy, time and money to creating life-saving and enhancing innovations that will benefit us all. This is why medical innovation is different and deserves to be treated differently.

For all the things that divide us as a nation, medical innovation should stand as a beacon for cooperation. We agree on the problems facing aging population and medical issues that affect too many people like obesity, cancer and heart disease. We agree that Social Security and Medicare and Medicaid are in trouble and that health care costs need to be addressed. Yet from financing to regulatory approval to employment law to tax policy, we miss opportunities to work together.

As mentioned in this article about an earlier post, we need to stop viewing medical innovation and medical innovators as something to be exploited and instead treat them as a critical national asset that benefits each and every one of us, our family and our nation. This is a great place for the Trump Administration and Democratic leaders to work together on an issue that benefits everyone.

You may also like

1 Comment

Leave a Reply

Your email address will not be published. Required fields are marked *